Selected article for: "low immunity and lung cancer"

Author: Hong-Yan Zhang; Lin-Wei Wang; Yuan-Yuan Chen; Xiao-Kun Shen; Qun Wang; You-Qin Yan; Yi Yu; Qiuji Wu; Xinghuan Wang; Ya-Hua Zhong; Melvin Chua Lee Kiang; Cong-Hua Xie
Title: A Multicentre Study of 2019 Novel Coronavirus Disease Outcomes of Cancer Patients in Wuhan, China
  • Document date: 2020_3_26
  • ID: 8rxjju0t_42
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.21.20037127 doi: medRxiv preprint proportion of all cancers; (2) 10 cases lung cancer patients were ongoing anticancer treatment, and they may have high risks of nosocomial infection and low immunity to SARS-CoV viral particles. Meanwhile, all 5 deaths with lung cancer is at anticancer treatment phase. This indicates that patients with lu.....
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.21.20037127 doi: medRxiv preprint proportion of all cancers; (2) 10 cases lung cancer patients were ongoing anticancer treatment, and they may have high risks of nosocomial infection and low immunity to SARS-CoV viral particles. Meanwhile, all 5 deaths with lung cancer is at anticancer treatment phase. This indicates that patients with lung cancer at anticancer treatment phase might have poor prognosis. The proportion of severe cases among different kinds of cancer types ranged from 25.0% to 64.7%, of which digestive system cancer patients ranked the highest. However, it is still unclear whether there are any differences in the severity of SARS-CoV-2 infection among other types of cancer. More data is needed to further verify our findings.

    Search related documents:
    Co phrase search for related documents